ArticleFrontiers in cardiovascular medicine2022
Surgery for Primary Cardiac Tumors in Children: Successful Management of Large Fibromas.
Article in Frontiers in cardiovascular medicine, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
7 citing papers in PubMed.
- Article
- A rare case of pediatric cardiac fibroma arising from the pulmonary valve and right ventricular outflow tract presenting with obstructive hemodynamics.Journal of cardiology cases · 2026Article
- Life-threatening arrhythmias from dynamic LVOT obstruction by a large left ventricular fibroma in an adolescent: complete resolution after combined transaortic-transatrial resection-a case report.Frontiers in cardiovascular medicine · 2026Article
- Case Report: Surgical resection of giant ventricular fibroma in an infant utilizing 3D imaging guidance.Frontiers in cardiovascular medicine · 2025Article
- Right Ventricular Myxoma Involving the Chordae Tendineae: A Case Report and Literature Review.Cureus · 2024Article
- Differential diagnosis of cardiac tumors: General consideration and echocardiographic approach.Journal of clinical ultrasound : JCU · 2022Review
- Current status of diagnosis and treatment of primary benign cardiac tumors in children.Frontiers in cardiovascular medicine · 2022Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Pediatric primary cardiac tumors (PCTs) are rare. Its clinical features and prognoses are not well defined. The management of asymptomatic patients with cardiac fibromas remains controversial. Objective: We aimed to examine our experience in surgical resection of pediatric PCT, with specific focuses on the management of large fibromas. Methods: This study included all the children who underwent surgical resection of PCT in our institution between December 2008 and June 2021. The last follow-up was performed between June 1st and August 26th, 2021. Kaplan-Meier method was used to estimate the postoperative survival, freedom from reoperation, event-free survival, and also related risk factors. The tumor volume and volume index (volume divided by body surface area) were measured for cardiac fibromas. Results: Of the 39 patients with median operative age of 9.5 [interquartile range (IQR): 1.2-16.5] years, 35 (89.7%) had benign tumors (fibromas for 15, myxomas for 13, and others for 7). The length and volume of fibromas were independent of age and symptoms ( Conclusion: Pediatric surgery for PCT can be performed with low mortalities and few adverse events. The size of cardiac fibroma in children relatively decreases with the increase of age. Larger tumor volume index than LV end-diastolic volume index and transmural tumor resection predicts postoperative LV dysfunction.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.